Evidence map›Paper›PMID 20129661›Full record

ArticleBiomaterials2010

The effects of Runx2 immobilization on poly (epsilon-caprolactone) on osteoblast differentiation of bone marrow stromal cells in vitro.

Ying Zhang, Xiaopei Deng, Erica L Scheller, Tae-Geon Kwon, Joerg Lahann, Renny T Franceschi, Paul H Krebsbach

Abstract read
In one paragraph

Article in Biomaterials, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Multigrowth Factor Delivery via Immobilization of Gene Therapy Vectors.Advanced materials (Deerfield Beach, Fla.) · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ying ZhangDepartment of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI 48109-1078, USA.
Xiaopei Deng
Erica L Scheller
Tae-Geon Kwon
Joerg Lahann
Renny T Franceschi
Paul H Krebsbach
University of Michigan–Ann Arbor · USKyungpook National University · KR

Funding

GENE THERAPY APPROACH FOR ENGINEERING CRANIOFACIAL BONER01DE013386 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FRANCESCHI, RENNY THEODORE · 2000 to 2011
$2.8M
Engineering Multi-Tissue InterfacesR01DE018890 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KREBSBACH, PAUL HUGO · 2008 to 2012
$1.8M
NIDCR NIH HHS DE13386NIDCR NIH HHS R01 DE013386NIDCR NIH HHS R01 DE018890
6 · The paper itself

Abstract

In vivo regenerative gene therapy is a promising approach for bone regeneration and can help to address cell-source limitations through surgical implantation of osteoinductive materials and subsequent recruitment of host-derived cells. Localized viral delivery may reduce the risk of virus dispersion, enhance transduction efficiency, and reduce administration/injection dosing, which subsequently increases patient safety. In this manuscript, we present a custom-tailored strategy to immobilize adenovirus expressing runt-related transcription factor 2 (AdRunx2) by using reactive polymer coatings to enhance in vitro osteoblast differentiation of bone marrow stromal cells (BMSCs). A thin polymer film of poly[p-xylylene carboxylic acid pentafluorophenol ester-co-p-xylylene] equipped with amine-reactive active ester groups was deposited on the surface of poly (epsilon-caprolactone) (PCL) using the chemical vapor deposition (CVD) polymerization technique and then anti-adenovirus antibody was conjugated on the material with an amide chemical bond. Following antibody conjugation, AdRunx2 was conjugated to the PCL surface through antibody-antigen interaction. Osteoblast differentiation of BMSCs was induced by incubation in osteogenic medium. Alkaline phosphatase (ALP) activity, calcium deposition, and matrix mineralization were confirmed as markers of osteoblast formation. Incubation of the BMSCs in the presence of AdRunx2 modified PCL resulted in a 6.5-fold increase in ALP activity and significant increases in matrix mineralization when compared to controls. These results demonstrate that adenovirus vectors driving the expression of transcription factors can be delivered directly from biomaterials to direct cell differentiation.

Indexed as

Cell DifferentiationPolyestersAlkaline PhosphataseAnimalsBlotting, WesternBone Marrow CellsCore Binding Factor Alpha 1 SubunitMiceMice, Inbred C57BLOsteoblastsStromal CellsAlkaline PhosphataseCore Binding Factor Alpha 1 SubunitpolycaprolactonePolyestersRunx2 protein, mouse

Identifiers

PMID20129661
PMCPMC2830730
OpenAlexW2091049165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.